NM_001243540.2:c.44+4196T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001243540.2(CEP295NL):​c.44+4196T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 152,138 control chromosomes in the GnomAD database, including 9,125 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 9122 hom., cov: 32)
Exomes 𝑓: 0.19 ( 3 hom. )

Consequence

CEP295NL
NM_001243540.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.14

Publications

15 publications found
Variant links:
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.609 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP295NLNM_001243540.2 linkc.44+4196T>C intron_variant Intron 2 of 2 ENST00000322630.3 NP_001230469.1 Q96MC4
TIMP2NM_003255.5 linkc.131-23670T>C intron_variant Intron 1 of 4 ENST00000262768.11 NP_003246.1 P16035A0A140VK57

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP295NLENST00000322630.3 linkc.44+4196T>C intron_variant Intron 2 of 2 2 NM_001243540.2 ENSP00000312767.2 Q96MC4
TIMP2ENST00000262768.11 linkc.131-23670T>C intron_variant Intron 1 of 4 1 NM_003255.5 ENSP00000262768.6 P16035

Frequencies

GnomAD3 genomes
AF:
0.270
AC:
41059
AN:
151954
Hom.:
9093
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.616
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.155
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.0880
Gnomad FIN
AF:
0.122
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.143
Gnomad OTH
AF:
0.236
GnomAD4 exome
AF:
0.188
AC:
12
AN:
64
Hom.:
3
Cov.:
0
AF XY:
0.190
AC XY:
8
AN XY:
42
show subpopulations
African (AFR)
AF:
0.500
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.174
AC:
8
AN:
46
Other (OTH)
AF:
0.500
AC:
3
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.271
AC:
41144
AN:
152074
Hom.:
9122
Cov.:
32
AF XY:
0.263
AC XY:
19551
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.616
AC:
25506
AN:
41434
American (AMR)
AF:
0.155
AC:
2369
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
494
AN:
3470
East Asian (EAS)
AF:
0.126
AC:
651
AN:
5166
South Asian (SAS)
AF:
0.0874
AC:
422
AN:
4826
European-Finnish (FIN)
AF:
0.122
AC:
1297
AN:
10594
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.143
AC:
9744
AN:
67980
Other (OTH)
AF:
0.242
AC:
510
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1179
2359
3538
4718
5897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.177
Hom.:
6666
Bravo
AF:
0.289
Asia WGS
AF:
0.160
AC:
557
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.76
DANN
Benign
0.28
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744787; hg19: chr17-76893671; API